Medtech Insight Will Hold its Next 'Investment In Innovation -In3-: A Preview of Early-Stage Medical Technology Companies' Conference in San Francisco on June 8-9, 2004.

Business Editors/Health/Medical Writers

Medtech Insight 2004 Investment In Innovation

San Francisco, June 8-9, 2004

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--March 2, 2004

Medtech Insight LLC, a leading provider of business information on new trends, technologies and emerging companies in the medical device industry, will hold its 11th "Investment In Innovation (In3): A Preview of Early-Stage Medical Technology Companies" conference June 8-9, 2004 at The Palace Hotel in San Francisco. Medtech Insight's In3 conferences are the premier forum for senior executives in the medical device, diagnostics and investment communities to preview early-stage medical technology companies in need of funding, acquisition and/or strategic partnership.

This two-day event will showcase over 50 innovative, emerging medical start-up companies that will present to an audience of over 300 senior executives, representing the top medical technology and investment firms from around the world. The forum will include focused 10-minute presentations by a senior executive from each presenting company, followed immediately by one-on-one meetings with company representatives in private breakout rooms. The meeting will also feature tabletop exhibits and product prototypes by presenting companies during a networking dinner on June 8, and keynote presentations by respected opinion leaders.

"Our 'Investment In Innovation' conferences continue to draw brand new early-stage medical technology companies," reported Sharon O'Reilly, president and CEO of Medtech Insight. "At our recent conference in Irvine, nearly 70% of the 50-plus presenting companies were new to our program, with many of them debuting their technologies for the first time."

In3 San Francisco is a must-attend event for anyone interested in emerging medical technology. To register to attend, or if your company is interested in presenting, call Medtech Insight at 949-219-0150, or 888-290-2225 toll-free in the United States, or register on the Medtech Insight Web site: http://www.medtechinsight.com/in3-11.html. Through March 31, attendees registering for the conference can save $300 off the $1,395 registration fee.

Presenting companies will represent a wide range of advanced technologies and clinical areas -- see http://www.medtechinsight.com/pastpresenters.html for a full list of previous presenters and their technology descriptions. Medtech Insight's 10 previous In3 conferences have drawn a total over 3,000 attendees (see http://www.medtechinsight.com/pastattendees.html) and more than 375 innovative early-stage presenting companies (see http://www.medtechinsight.com/pastpresenters.html). To read what industry experts think of Medtech Insight's In3 events, please visit http://www.medtechinsight.com/in3success.html.

Co-sponsors for the In3 San Francisco event include AdvaMed, Battelle, Business Wire, Dorsey & Whitney LLP, Medmarc and The Hartford, The MedTech Group, PPD Development, Reimbursement Principles, Ronald Trahan Associates, Underwriters Laboratories and Windhover Information.

Medtech Insight is publisher of the "medtech insight" newsletter, covering the latest trends and innovations in the medical device industry. The company publishes analyses of medical technology markets through its Reports group, holds "Investment In Innovation" conferences several times a year for emerging medical technology companies and potential investors, and provides custom market research through its Consulting group. For more information on this upcoming conference or to register, please contact Scott Pantel at Medtech Insight at 949-219-0150, 888-290-2225 toll-free in the United States, e-mail [e-mail], or visit http://www.medtechinsight.com/in3-11.html. Visit the company's Web site, www.medtechinsight.com, to view tables of contents for published and upcoming Market & Technology reports, and to download a sample issue of the "medtech insight" newsletter.